Japan covid news update... Aug 28
Takeover to advance T-Cell Activator Solid Tumor Treatments and expand new Cancer Immunotherapy Portfolio... Mar 13
This collaboration will help Crescendo’s proprietary transgenic platform and engineering expertise are being used to build Humabody-based therapeutics against certain targets selected by ... Dec 11
Takeda Pharmaceutical Company Limited today announced top-line results from the Phase 3 clinical trial evaluating the efficacy and safety of the investigational drug TAK-... Dec 04
Takeda Pharmaceutical Company Limited completes its previously-announced sale of a portfolio of select products to Celltrion Inc... Dec 01
Takeda expands COVID-19 vaccine supply in Japan through partnership with Moderna and Government of Japan ... Oct 29
Takeda establishes new cell drug manufacturing facility for research and development to support expansion of next-generation clinical programs ... Sep 19
Novavax partners with Takeda for manufacturing and marketing covid vaccine in Japan... Aug 08
Multiple myeloma is a life-threatening rare blood cancer that arises from the plasma cells, a type of white blood cell that is made in ... Mar 12
Investigational medicine TAK-062 is an oral computationally engineered super glutenase designed to improve the digestion of gluten. Successful “build to buy” relationship adds second ... Feb 27
-Advertisements-
.jpeg)
Thursday, October 08, 2026
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)